Skyscape Web Viewer : Fischbach's Manual of Laboratory and Diagnostic Tests : Main Index

View All
Preterm labor
Pretest Phase: Elements of Safe, Effective, Informed Care
Pretest phase
Prevalence Clinical Value of a Test Diagnostic Testing Grading Guidelines for Scientific Evidence Overview of Laboratory and Diagnostic Testing
Primary septicemic plague infection, diagnosis of
Prion proteins
Privacy Diagnostic Testing Elements of Safe, Effective, Informed Care Throughout the Testing Process Ethics and the Law Patient's Bill of Rights and Patient Responsibilities
Proctoscopy, flexible
Proctosigmoidoscopy
Professional practice parameters
Progesterone drug effects on Progesterone
Progesterone receptor (PR) Breast Biopsy Cytologic, Histologic, and Genetic Studies Cytologic and Histologic Studies Estrogen/Estradiol Receptor (ER), Progesterone Receptor (PR) Histologic (Tissue) Study and DNA Ploidy (Tumor Aneuploidy) Histologic (Tissue) Biopsy Studies
Prognostic markers, tumor Cytologic, Histologic, and Genetic Studies Cytologic and Histologic Studies Histologic (Tissue) Biopsy Studies Immunodiagnostic Studies Protein Chemistry Testing/Serum Proteins: Acute-Phase Proteins and Cytokines Tumor Markers Useful Information from a Single Biopsy Specimen
Prolactin (hPRL) drug effects on Prolactin (hPRL)
Proliferating cell nuclear antigen (PCNA) Cytologic, Histologic, and Genetic Studies Cytologic and Histologic Studies Histologic (Tissue) Biopsy Studies
Proliferative index Cytologic, Histologic, and Genetic Studies Cytologic and Histologic Studies Histologic (Tissue) Biopsy Studies
Prone position Administration of Drugs and Solutions Diagnostic Testing Intratest Phase: Elements of Safe, Effective, Informed Care Management of Environment Positioning for Procedures Presence of Family or Significant Others
Prophylactic antifungals Safe Practice Domains for Specific Situations Standard Precautions for Prevention and Control of Infection
Prophylactic anti-infectives Safe Practice Domains for Specific Situations Standard Precautions for Prevention and Control of Infection
Prostaglandins, as tumor markers
ProstaScint imaging Overview of Monoclonal Antibody Tumor Imaging Prostascint Imaging
Prostate biopsy Cytologic, Histologic, and Genetic Studies Cytologic and Histologic Studies Histologic (Tissue) Biopsy Studies Sentinel Node Location Before Biopsy (Breast, Melanoma)
Prostate cancer nuclear medicine study in oncoprofile in tumor markers in
Prostate-specific antigen (PSA) Goals of Test Selection with Examples Prostate-Specific Antigen (PSA) Suggested Age-Specific Prostate-Specific Antigen (PSA) Reference Ranges Tumor-Specific and Tumor-Associated Agents
Prostate ultrasound
Prostatic acid phosphatase (PAP) Acid Phosphatase; Prostatic Acid Phosphatase (PAP) Tumor-Specific and Tumor-Associated Agents
Protamine sulfate test Blood Studies: Hematology and Coagulation Fibrin Monomers (Protamine Sulfate Test; Fibrin Split Products) Laboratory Tests to Measure Hemostasis Tests for Disseminated Intravascular Coagulation (DIC) Tests of Hemostasis and Coagulation
Protected health information (PHI) Diagnostic Testing Elements of Safe, Effective, Informed Care Throughout the Testing Process Ethics and the Law Patient's Bill of Rights and Patient Responsibilities
Protein, CSF (total) CSF Total Protein drug effects on
Protein, urine Collection of Urine Specimens drug effects on Long-Term, Timed Urine Specimen (2-Hour, 24-Hour) Routine Urinalysis (Ua) and Related Tests Urine Protein (Albumin), Qualitative and 24-Hour Urine Studies Urine Testing by Dipstick/Reagent Strip